This story has been edited to correct an erroneous description of drugs that keep HIV from spreading in the body as antivirals. Such drugs are known as antiretrovirals.

Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...

Now millions of people take drugs known as antivirals that keep HIV from spreading in the body. Stopping those drugs lets the virus start multiplying in the body again, and it could become drug ...

OLYMPIA, Wash.–A Washington bill that would ensure the Medicaid program in the state continues covering HIV antiviral dugs ...

Gilead Sciences sets aside $200 million for a potential settlement over its HIV drug promotional speaker program amid federal investigation.

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...